Reproducibility in the bioreactor: how to structurally eliminate batch variation with the right mass flow controller

Bioreactor reproducibility cannot be taken for granted. This article explains where variability really comes from, how to recognise it in your own installation and what you can do about it structurally.

⏱ approx. 8 minutes reading time

Your bioreactor gives inconsistent results. What is going on?

Suppose your bioprocesses run on the same settings, the same protocol, the same team. Yet batch 2 deviates from batch 1. Reactor 3 performs 8% worse than the rest. The pH does not stabilise. You look for the cause in the biology, in the media composition, in the inoculation. But the real cause is almost never biological in nature.

In the bioprocess industry, from pharmaceutical cell culture to industrial fermentation, reproducibility is at the heart of quality. What many process engineers and R&D teams overlook, however, is that reproducibility starts with the gas supply. The mass flow controller (MFC) that controls pH, CO2 concentration and dissolved oxygen is the most underestimated variable in the system.

Gas is invisible. Small deviations in gas flow are not immediately noticeable on the shop floor, but they accumulate over process time and batches. By the time deviations become visible in process results, they have long been present. This article explains how that mechanism works, which five specific causes undermine reproducibility, how to recognise them and how to solve them structurally.

Key message for process engineers and R&D

Reproducible bioprocesses are not a matter of biological luck. They arise when the same setpoint always has the same physical effect, today, tomorrow and a year from now. The key lies in the precision, stability and diagnostic transparency of your gas supply system

Why gas control is at the heart of process reproducibility

A bioreactor controls its process conditions via a closed control loop. pH, dissolved oxygen and CO2 concentration are continuously measured and adjusted by adding gases such as CO2, air, nitrogen and oxygen. The mass flow controller is the physical executing element in that chain: it converts an electrical signal into a precisely dosed gas flow.

The problem is that, in practice, the MFC is rarely regarded as a critical component. It is tucked away in a rack, far from the visible process, and is rarely included in maintenance programmes. Yet the quality of its output directly determines the quality of your process.

Reproducibility requires five conditions to be met simultaneously. When one of these five fails, you introduce variability into your bioprocess, often without knowing it.

• The same setpoint always delivers the same gas volume, regardless of the time or calibration history.
• Small process adjustments are carried out accurately and stably, even at low flow rates.
• Identical MFC units behave identically, so that parallel reactors really do run in parallel.
• Environmental factors such as temperature differences in the installation cabinet have no effect on the flow.
• Deviations in the gas dosing system can be detected early, before they affect process results.

Five causes that undermine bioreactor reproducibility

Based on extensive field experience and technical analysis, Vögtlin Instruments has mapped the most common gas-related causes of batch variation. They are discussed below as a coherent series, because in practice they rarely occur in isolation.

1. The coarse correction

A mass flow controller with a low resolution doses gas in steps that are too coarse: too little, then too much, then adjusting again. The control loop responds with constant readjustment, but never achieves real stability. The result is that each batch runs under slightly different conditions, despite identical setpoints.

What you see:

Your pH curve over a period of a few hours looks like a wavy line instead of a stable straight one. The system makes adjustments, but the pH does not stabilise at the setpoint.

The technical cause:

The resolution and dynamic range of the MFC determine how accurately dosing can take place. A high turndown ratio (up to 1:1000) allows precise corrections even at low flow rates and is therefore a fundamental requirement for stable pH control in bioprocesses.

2. The calibration illusion

Six months ago, setpoint X delivered exactly the expected gas flow. Today, the same setpoint delivers 3% more. The control loop compensates for this automatically. The display shows stable values. But the actual process conditions have changed, and reproducibility is gradually lost without this being immediately visible.

What you see:

Batch results that gradually deviate from previous batches, without anything demonstrably having changed in the protocol or settings.

The technical cause:

The long-term stability of the MFC sensor directly determines the reproducibility of your process results. Drift in the sensor changes the relationship between setpoint and actual flow. An MFC that remains stable within 1% over 7 years virtually eliminates this source of variability.

Relevant for GMP and FDA-regulated environments

In regulated bioprocesses, calibration drift is considered a critical risk factor. Systematic deviations that only become visible after weeks or months are particularly problematic in an audited environment, because they cannot easily be traced back to a specific cause.

3. The twin paradox

Ten identical reactors, ten identical protocols, ten identical MFC units. But reactor 3 consistently yields 8% less. The cause lies neither in the biology nor in the protocol. It lies in small, systematic differences in the dosing behaviour of the individual MFC units.

What you see:

One or more reactors in a parallel set-up perform structurally differently, without any identifiable process-related reason.

The technical cause:

Unit-to-unit consistency is crucial for multi-reactor set-ups and parallel screening studies. An inter-unit variation of less than 0.5% guarantees that all reactors really operate identically. This is a specification that must be explicitly requested when purchasing MFC units.

4. The oven effect

Your installation cabinet shows 18 degrees Celsius at a cold start and 55 degrees after 8 hours of operation. Without active temperature compensation, this rise causes a variation in the actual gas flow of up to 5%. The same setpoint delivers different gas volumes at different times of day. Your MFC behaves like a thermometer.

What you see:

Process parameters that gradually deviate from the initial values during a run, or batches that perform better after a morning start than after a full day of operation.

The technical cause:

Without active temperature compensation, the physical property of the measuring element changes with the ambient temperature. Dual-temperature calibration eliminates temperature drift up to 60 degrees Celsius, so that the MFC remains accurate regardless of the heat in the cabinet.

Practical check

Measure the temperature in your installation cabinet at a cold start and after 6 to 8 hours of operation. A difference of more than 10 degrees Celsius is a warning sign for temperature-related flow variations in your bioprocess.

5. Diagnostic blind flight

Your control system works with clearly defined setpoints. If the actual behaviour of the MFC is unstable or opaque, the control loop responds to incorrect assumptions. PID control and MFC response must be compatible. If they are not, overshoot, slow response or unexplained process variations occur.

What you see:

Deviations that only become visible in the process results, long after they originated in the gas dosing system. By then, the cause is virtually impossible to trace.

The technical cause:

Gas is invisible. Without diagnostic functionality in the MFC, deviations remain hidden until they manifest themselves in batch results. MFC systems with transparent diagnostics and PID tuning support make it possible to actively monitor the gas dosing system and flag deviations proactively.

Troubleshooting: recognise the cause in your own installation

In practice, the five causes above manifest themselves as three recognisable symptom patterns. Each pattern has a diagnostic step-by-step plan and concrete actions in both the short and long term. The combination of short- and long-term approaches is deliberate: you can take measures today, while working on structural improvement at the same time.

Pattern 1: pH and dissolved oxygen do not stabilise

The bioprocess makes constant adjustments but does not reach a stable state. The pH fluctuates around the setpoint. The dissolved oxygen level shifts constantly. The system works, but never comes to rest.

Pattern 2: Batch results are unpredictable

Batch 1 delivers the expected results, batch 2 performs moderately with exactly the same protocol. There is no demonstrable difference in approach. It feels like coincidence, but it is not.

Pattern 3: Stable in the lab, problematic at scale-up

The bench-scale reactor works well. However, the pilot plant or production scale shows erratic pH and dissolved oxygen behaviour, despite correctly scaled biological parameters. The scale-up itself appears to be the problem.

Scale-up checklist: five questions for every transition to a new process scale

With every transition in process scale, from bench scale to pilot, from pilot to production, the impact of gas flow variability increases. Small inaccuracies that are still acceptable at lab scale become significant at a larger scale. The following five questions will help you systematically assess gas handling at every scale-up step.

Which MFC specifications are critical for bioreactors?

Not every mass flow controller is suitable for the demanding conditions of bioprocesses. The table below links the process requirement directly to the MFC specification, so that you can ask the right questions when purchasing or evaluating.

Conclusion: reproducibility requires method, not luck

Inconsistent batch results, pH instability and inexplicable scale-up problems are rarely biological in nature. They can almost always be traced back to variability in the gas supply, caused by one of the five mechanisms described in this article.

The solution does not require a fundamental overhaul of your bioprocess. It requires a critical look at the specifications of your mass flow controller and a structured approach to calibration, temperature management and control loop tuning.

For organisations in the Netherlands and Belgium working with bioreactors for pharma, biotechnology, food technology or industrial fermentation, Vögtlin Instruments offers access via Inacom to MFC technology specifically developed for reproducible bioprocesses. From lab scale to GMP production.

Does your bioreactor deliver truly reproducible results?

In addition to the switching output, ChemTec flow monitors such as the FAV and LCA also have a visible indicator: a float or vane wheel that shows the operator on site whether there is flow. This makes them useful as a stand-alone visual instrument and as an electrical monitoring component at the same time. A flow meter without a switching output does not offer this alarm function without additional configuration.

Our gas flow specialists analyse your MFC specifications free of charge and identify hidden causes of variability in your bioreactor set-up. Without obligation.

Request your free Reproducibility Screening from Vögtlin

Mass flow controllers